Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20058177HPVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS20041182HPVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS20058236HPVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS20058541HPVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS20058450HPVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS20058625HPVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS20058973HPVENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS44005801HTLV-1ENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS44030180HTLV-1ENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TVIS44022244HTLV-1ENSG00000151623.15protein_codingNR3C2NoNo4306B0ZBF6
P08235
TCGA Plot Options
Drug Information
GeneNR3C2
DrugBank IDDB00624
Drug NameTestosterone
Target IDBE0000668
UniProt IDP08235
Regulation Typeligand
PubMed IDs17105867
CitationsTakeda AN, Pinon GM, Bens M, Fagart J, Rafestin-Oblin ME, Vandewalle A: The synthetic androgen methyltrienolone (r1881) acts as a potent antagonist of the mineralocorticoid receptor. Mol Pharmacol. 2007 Feb;71(2):473-82. Epub 2006 Nov 14.
GroupsApproved; Investigational
Direct ClassificationAndrogens and derivatives
SMILES[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
PathwaysAromatase Deficiency; Androgen and Estrogen Metabolism; 17-beta Hydroxysteroid Dehydrogenase III Deficiency; Androstenedione Metabolism
PharmGKBPA451627
ChEMBLCHEMBL386630